Belluscura PLC (GB:BELL) has released an update.
Belluscura PLC, a UK-based medical device developer, has successfully raised approximately £1.92 million through a combination of £1.71 million in convertible loan notes and £0.21 million through new ordinary share subscriptions to support the sales growth of its portable oxygen concentrator devices, X-PLOR and DISCOV-R. The funds are anticipated to fuel the company’s expansion, particularly in the North American market, following positive sales trends and preliminary orders for their latest oxygen technology products. The fundraising is subject to shareholder approval at a forthcoming General Meeting.
For further insights into GB:BELL stock, check out TipRanks’ Stock Analysis page.
